Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?

Human Pathology

Volumn 40, Issue 4, 2009, Pages 558-564

  Kunju, Lakshmi P ^a   Daignault, Stephanie ^a   Wei, John T ^a   Shah, Rajal B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Core needle biopsy; Gleason score; Prostate cancer

Indexed keywords

ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CONTAINER; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

BIOPSY, NEEDLE; HUMANS; MALE; PATHOLOGY, SURGICAL; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 62049084377     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.07.020     Document Type: Article

References (26)

1. Kattan M.W., and Eastham J. Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer. Clin Prostate Cancer 1 (2003) 221-226
2. Kattan M.W., Eastham J.A., Stapleton A.M., Wheeler T.M., and Scardino P.T. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771
3. Narayan P., Gajendran V., Taylor S.P., et al. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology 46 (1995) 205-212
4. Partin A.W., Mangold L.A., Lamm D.M., Walsh P.C., Epstein J.I., and Pearson J.D. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 (2001) 843-848
5. Pisansky T.M., Kahn M.J., Rasp G.M., Cha S.S., Haddock M.G., and Bostwick D.G. A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma. Cancer 79 (1997) 337-344
6. Bostwick D.G. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 18 (1994) 796-803
7. King C.R. Patterns of prostate cancer biopsy grading: trends and clinical implications. Int J Cancer 90 (2000) 305-311
8. Steinberg D.M., Sauvageot J., Piantadosi S., and Epstein J.I. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 21 (1997) 566-576
9. Naya Y., Ochiai A., Troncoso P., and Babaian R.J. A comparison of extended biopsy and sextant biopsy schemes for predicting the pathological stage of prostate cancer. J Urol 171 (2004) 2203-2208
10. Siu W., Dunn R.L., Shah R.B., and Wei J.T. Use of extended pattern technique for initial prostate biopsy. J Urol 174 (2005) 505-509
11. Arora R., Koch M.O., Eble J.N., Ulbright T.M., Li L., and Cheng L. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 100 (2004) 2362-2366
12. Mehra R., Han B., Tomlins S.A., et al. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res 67 (2007) 7991-7995
13. Epstein J.I., Allsbrook Jr. W.C., Amin M.B., and Egevad L.L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29 (2005) 1228-1242
14. Poulos C.K., Daggy J.K., and Cheng L. Preoperative prediction of Gleason grade in radical prostatectomy specimens: the influence of different Gleason grades from multiple positive biopsy sites. Mod Pathol 18 (2005) 228-234
15. Kunz Jr. G.M., and Epstein J.I. Should each core with prostate cancer be assigned a separate Gleason score?. Hum Pathol 34 (2003) 911-914
16. Iczkowski K.A., and Bostwick D.G. Sampling, submission, and report format for multiple prostate biopsies: a 1999 survey. Urology 55 (2000) 568-571
17. Mosse C.A., Magi-Galluzzi C., Tsuzuki T., and Epstein J.I. The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens. Am J Surg Pathol 28 (2004) 394-398
18. Sim H.G., Telesca D., Culp S.H., et al. Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence. J Urol (2008)
19. Epstein J.I., Partin A.W., Sauvageot J., and Walsh P.C. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 20 (1996) 286-292
20. Lattouf J.B., and Saad F. Gleason score on biopsy: is it reliable for predicting the final grade on pathology?. BJU Int 90 (2002) 694-698 discussion 698-99
21. Cookson M.S., Fleshner N.E., Soloway S.M., and Fair W.R. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 157 (1997) 559-562
22. King C.R., McNeal J.E., Gill H., and Presti Jr. J.C. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys 59 (2004) 386-391
23. San Francisco I.F., DeWolf W.C., Rosen S., Upton M., and Olumi A.F. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol 169 (2003) 136-140
24. Amin M., Boccon-Gibod L., Egevad L., et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl (2005) 20-33
25. Gupta C., Ren J.Z., and Wojno K.J. Individual submission and embedding of prostate biopsies decreases rates of equivocal pathology reports. Urology 63 (2004) 83-86
26. Rubin M.A., Bismar T.A., Curtis S., and Montie J.E. Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?. Am J Surg Pathol 28 (2004) 946-952